{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:21:58Z","timestamp":1793766118774,"version":"4.6.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":51,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48852-1","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:03:46Z","timestamp":1776117826000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of serum TNF-\u03b1, IL-17\u00a0A, and IL-17\u00a0F levels with disease activity in Yemeni patients with rheumatoid arthritis"],"prefix":"10.1038","volume":"16","author":[{"given":"Amr A.","family":"Saleh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar K.","family":"Al-Madhaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan A.","family":"Al-Shamahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja M","family":"Al-Haimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan K.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"48852_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"J Smolen","year":"2018","unstructured":"Smolen, J. et al. Rheumatoid arthritis Nat. Rev. Dis. Primers 4, 18001 (2018).","journal-title":"Rheumatoid arthritis Nat. Rev. Dis. Primers"},{"issue":"3","key":"48852_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.31138\/mjr.20230801.oo","volume":"34","author":"M Jahid","year":"2023","unstructured":"Jahid, M., Khan, K. U. & Ahmed, R. S. Overview of rheumatoid arthritis and scientific understanding of the disease. Mediterr. J. Rheumatol. 34 (3), 284\u2013291 (2023).","journal-title":"Mediterranean J. Rheumatol."},{"issue":"10","key":"48852_CR3","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"RJ Black","year":"2023","unstructured":"Black, R. J. et al. Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 5 (10), e594\u2013e610 (2023).","journal-title":"Lancet Rheumatol."},{"key":"48852_CR4","doi-asserted-by":"crossref","unstructured":"Cai, Y. et al. The burden of rheumatoid arthritis: Findings from the 2019 Global Burden of diseases study and forecasts for 2030 by Bayesian age-period-cohort analysis. J. Clin. Med. 12(4). (2023).","DOI":"10.3390\/jcm12041291"},{"key":"48852_CR5","doi-asserted-by":"crossref","unstructured":"Maranini, B., Bortoluzzi, A., Silvagni, E. & Govoni, M. Focus on sex and gender: What we need to know in the management of rheumatoid arthritis. J. Pers. Med. 12(3). (2022).","DOI":"10.3390\/jpm12030499"},{"issue":"1","key":"48852_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.20428\/yjms.v14i1.1722","volume":"14","author":"RM Al-Haimi","year":"2020","unstructured":"Al-Haimi, R. M., Othman, A. M., Al-Shamahy, H. A., Al-Moyed, K. A. & Al-Selwi, A. H. A. Common autoimmune diseases among yemeni patients in Sana\u2019a City, Yemen. Yemeni J. Med. Sci. 14 (1), 22\u201327 (2020).","journal-title":"Yemeni J. Med. Sci."},{"issue":"1","key":"48852_CR7","doi-asserted-by":"publisher","first-page":"19297","DOI":"10.1038\/s41598-022-22310-0","volume":"12","author":"SE Mousavi","year":"2022","unstructured":"Mousavi, S. E. et al. The burden of rheumatoid arthritis in the Middle East and North Africa region, 1990\u20132019. Sci. Rep. 12 (1), 19297 (2022).","journal-title":"Sci. Rep."},{"issue":"3","key":"48852_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.7861\/clinmedicine.10-3-248","volume":"10","author":"DP Symmons","year":"2010","unstructured":"Symmons, D. P. Rheumatoid arthritis: assessing disease activity and outcome. Clin. Med. 10 (3), 248\u2013251 (2010).","journal-title":"Clin. Med."},{"issue":"3","key":"48852_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.37349\/ei.2024.00146","volume":"4","author":"J Heo","year":"2024","unstructured":"Heo, J. et al. Rheumatoid arthritis: A complex tale of autoimmune hypersensitivity. Explor. Immunol. 4 (3), 358\u2013375 (2024).","journal-title":"Explor. Immunol."},{"key":"48852_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.molimm.2025.06.008","volume":"184","author":"S Ganeshalingam","year":"2025","unstructured":"Ganeshalingam, S., Wilson, N. J., Ciciriello, S., Antonipillai, J. & Achuthan, A. A. Cellular interactions in maintaining an inflammatory microenvironment in rheumatoid arthritis. Mol. Immunol. 184, 112\u2013122 (2025).","journal-title":"Mol. Immunol."},{"issue":"8","key":"48852_CR11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1089\/jir.2023.0078","volume":"43","author":"M Lama","year":"2023","unstructured":"Lama, M., Sarkar, R. & Ghosh, B. Serum cytokine profiles in patients with rheumatoid arthritis before and after treatment with methotrexate. J. Interferon Cytokine Res. 43 (8), 344\u2013350 (2023).","journal-title":"J. Interferon Cytokine Res."},{"issue":"2","key":"48852_CR12","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.4110\/in.2025.25.e2","volume":"25","author":"SK Ziyadullaev","year":"2025","unstructured":"Ziyadullaev, S. K. et al. Synovial fluid as a crucial component of the joint microenvironment in rheumatoid arthritis. Immune Netw. 25 (2), e2 (2025).","journal-title":"Immune Netw."},{"issue":"3","key":"48852_CR13","doi-asserted-by":"publisher","first-page":"e509","DOI":"10.1002\/mco2.509","volume":"5","author":"Y Gao","year":"2024","unstructured":"Gao, Y., Zhang, Y. & Liu, X. Rheumatoid arthritis: Pathogenesis and therapeutic advances. MedComm 5 (3), e509 (2024).","journal-title":"MedComm"},{"issue":"7","key":"48852_CR14","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/art.41666","volume":"73","author":"K Yokota","year":"2021","unstructured":"Yokota, K. et al. Characterization and function of tumor necrosis factor and Interleukin-6\u2013Induced osteoclasts in rheumatoid arthritis. Arthritis Rheumatol. 73 (7), 1145\u20131154 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"48852_CR15","doi-asserted-by":"crossref","unstructured":"Kuai, J., Chen, Z., He, J., Wang, F. & Wei, W. Promising TNF-\u03b1 inhibitors: Targeting pathogenic TNF-\u03b1\/TNFR signaling to restore Th17\/Treg balance in rheumatoid arthritis. J. Pharm. Anal., 101382. (2025).","DOI":"10.1016\/j.jpha.2025.101382"},{"issue":"14","key":"48852_CR16","doi-asserted-by":"publisher","first-page":"e70876","DOI":"10.1096\/fj.202501452R","volume":"39","author":"Y Yuan","year":"2025","unstructured":"Yuan, Y. et al. TNF-\u03b1 promotes synovial inflammation and cartilage bone destruction in rheumatoid arthritis via NF\u2010\u03baB\/YY1\/miR\u2010103a\u20103p axis. FASEB J. 39 (14), e70876 (2025).","journal-title":"FASEB J."},{"issue":"1","key":"48852_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41577-022-00746-9","volume":"23","author":"KH Mills","year":"2023","unstructured":"Mills, K. H. IL-17 and IL-17-producing cells in protection versus pathology. Nat. Rev. Immunol. 23 (1), 38\u201354 (2023).","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"48852_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/ard-2023-224232","volume":"83","author":"V Navarro-Comp\u00e1n","year":"2024","unstructured":"Navarro-Comp\u00e1n, V. et al. ASAS consensus definition of early axial spondyloarthritis. Ann. Rheum. Dis. 83 (9), 1093 (2024).","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"48852_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s12276-024-01376-y","volume":"57","author":"S-Y Lee","year":"2025","unstructured":"Lee, S-Y. et al. mtSTAT3 suppresses rheumatoid arthritis by regulating Th17 and synovial fibroblast inflammatory cell death with IL-17-mediated autophagy dysfunction. Exp. Mol. Med. 57 (1), 221\u2013234 (2025).","journal-title":"Exp. Mol. Med."},{"key":"48852_CR20","doi-asserted-by":"crossref","unstructured":"Saran, A., Nishizaki, D., Lippman, S. M., Kato, S. & Kurzrock, R. Interleukin-17: A pleiotropic cytokine implicated in inflammatory, infectious, and malignant disorders (Cytokine & Growth Factor Reviews, 2025).","DOI":"10.1016\/j.cytogfr.2025.01.002"},{"issue":"1","key":"48852_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3897\/folmed.65.e72448","volume":"65","author":"P Selimov","year":"2023","unstructured":"Selimov, P. et al. Rheumatoid arthritis and the proinflammatory cytokine IL-17. Folia Med. 65 (1), 53\u201359 (2023).","journal-title":"Folia Med."},{"key":"48852_CR22","doi-asserted-by":"crossref","unstructured":"Shen, J., Chen, Y., Zhang, Y., Zhang, C. & Liu, H. Multifaceted roles of IL-17 in bone and tendon health. Int. J. Biol. Macromol. 139498. (2025).","DOI":"10.1016\/j.ijbiomac.2025.139498"},{"issue":"11","key":"48852_CR23","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.3899\/jrheum.190571","volume":"47","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Interleukin 17A and IL-17F expression and functional responses in rheumatoid arthritis and peripheral spondyloarthritis. J. Rhuematol. 47 (11), 1606\u20131613 (2020).","journal-title":"J. Rhuematol."},{"issue":"5","key":"48852_CR24","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.3390\/jcm14051735","volume":"14","author":"M Colina","year":"2025","unstructured":"Colina, M. & Campana, G. Precision medicine in rheumatology: The role of biomarkers in diagnosis and treatment optimization. J. Clin. Med. 14 (5), 1735 (2025).","journal-title":"J. Clin. Med."},{"issue":"1","key":"48852_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/00045632241285843","volume":"62","author":"D Sahin","year":"2025","unstructured":"Sahin, D., Di Matteo, A. & Emery, P. Biomarkers in the diagnosis, prognosis and management of rheumatoid arthritis: A comprehensive review. Ann. Clin. Biochem. 62 (1), 3\u201321 (2025).","journal-title":"Ann. Clin. Biochem."},{"key":"48852_CR26","doi-asserted-by":"crossref","unstructured":"El-Aghbary, D. A., Safa\u2019a, M. D. & Al-Moyed, K. A. Interleukin-22 serum levels in patients with rheumatoid arthritis in Sana\u2019a city, Yemen. Univers. J. Pharm. Res. 6\u201311. (2018).","DOI":"10.22270\/ujpr.v3i2.131"},{"key":"48852_CR27","doi-asserted-by":"crossref","unstructured":"Alhaj, A. Y., Al Wazeer, A., Abdulhafed, S. A. & Al, M. Rheumatoid arthritis: Prevalence, patterns of presentations and associated factors among arthritis patients in military hospital. Sana\u2019 (2022).","DOI":"10.65693\/masj.2022.v1i1.15"},{"issue":"4","key":"48852_CR28","doi-asserted-by":"publisher","first-page":"955","DOI":"10.15584\/ejcem.2025.4.17","volume":"23","author":"AH Abd Ali","year":"2025","unstructured":"Abd Ali, A. H. & Kharbat, F. M. Evaluating tumor necrosis factor-alpha and interleukin 17 as plasma biomarkers for rheumatoid arthritis diagnosis. Eur. J. Clin. Exp. Med. 23 (4), 955\u2013961 (2025).","journal-title":"Eur. J. Clin. Experimental Med."},{"key":"48852_CR29","doi-asserted-by":"crossref","unstructured":"Ebaid, A. M., Atwa, E., Mortada, M. A. & Bahri, H. A. Serum Interleukin-17 and its association with inflammation and bone remodeling in rheumatoid arthritis and hand osteoarthritis. Insights Musculoskelet. Ultrasound 15(11). (2025).","DOI":"10.3390\/diagnostics15111335"},{"issue":"9","key":"48852_CR30","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D. et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthr. Rhuem. 62 (9), 2569\u20132581 (2010).","journal-title":"Arthr. Rhuem."},{"issue":"5","key":"48852_CR31","first-page":"e15314","volume":"13","author":"M Inam Illahi","year":"2021","unstructured":"Inam Illahi, M. et al. Serum tumor necrosis factor-alpha as a competent biomarker for evaluation of disease activity in early rheumatoid arthritis. Cureus 13 (5), e15314 (2021).","journal-title":"Cureus"},{"issue":"4","key":"48852_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/1110-161X.168164","volume":"42","author":"AEI Elhewala","year":"2015","unstructured":"Elhewala, A. E. I., Soliman, S. G., Labeeb, A. A. A., Mousa, W. A. & Salah, D. Interleukin-17 level in rheumatoid arthritis patients and its relation to disease activity: A clinical and ultrasound study. Egypt. Rheumatol. Rehabili. 42 (4), 183\u2013187 (2015).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"issue":"5","key":"48852_CR33","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/acr.21649","volume":"64","author":"J Anderson","year":"2012","unstructured":"Anderson, J. et al. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res. 64 (5), 640\u2013647 (2012).","journal-title":"Arthritis Care Res."},{"issue":"1","key":"48852_CR34","doi-asserted-by":"publisher","first-page":"102021","DOI":"10.1016\/j.berh.2024.102021","volume":"39","author":"M Neto","year":"2025","unstructured":"Neto, M., Mendes, B., Albuquerque, F. & da Silva, J. A. P. Novel biomarkers in RA: Implication for diagnosis, prognosis, and personalised treatment. Best Pract. Res. Clin. Rheumatol. 39 (1), 102021 (2025).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"48852_CR35","doi-asserted-by":"publisher","first-page":"152740","DOI":"10.1016\/j.semarthrit.2025.152740","volume":"73","author":"J Avouac","year":"2025","unstructured":"Avouac, J., Kay, J. & Choy, E. Personalised treatment of rheumatoid arthritis based on cytokine profiles and synovial tissue signatures: potentials and challenges. Semin Arthritis Rheum. 73, 152740 (2025).","journal-title":"Semin Arthritis Rheum."},{"key":"48852_CR36","doi-asserted-by":"crossref","unstructured":"Alharbi, S. Depression in Saudi patients with rheumatoid arthritis. Open. Access. Rheumatol Res. Rev. 1\u20139. (2023).","DOI":"10.2147\/OARRR.S397489"},{"issue":"1","key":"48852_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s43166-022-00130-4","volume":"49","author":"HM Abdel-Naby","year":"2022","unstructured":"Abdel-Naby, H. M., El-Tawab, S. S., Rizk, M. M. & Aboeladl, N. A. Is interleukin-17 implicated in early knee osteoarthritis pathogenesis as in rheumatoid arthritis? Egypt. Rheumatol. Rehabil. 49 (1), 29 (2022).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"key":"48852_CR38","doi-asserted-by":"crossref","unstructured":"Eddaoudi, M. et al. The first biological choice in patients with rheumatoid arthritis: Data from the Moroccan register of biotherapies. Pan Afr. Med. J. 38(1). (2021).","DOI":"10.21203\/rs.3.rs-51813\/v1"},{"issue":"1","key":"48852_CR39","doi-asserted-by":"publisher","first-page":"28945","DOI":"10.1038\/s41598-024-80104-y","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang, W. et al. Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities. Sci. Rep. 14 (1), 28945 (2024).","journal-title":"Sci. Rep."},{"issue":"1","key":"48852_CR40","first-page":"1","volume":"52","author":"A El-Salawy","year":"2025","unstructured":"El-Salawy, A., Gado, S. & El-Banna, H. Cross link between monocyte chemotactic protein-1 and rheumatoid arthritis activity and progression. Egypt. Rheumatol. Rehabil. 52 (1), 1\u20137 (2025).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"issue":"1","key":"48852_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s43166-020-00041-2","volume":"47","author":"EA Baraka","year":"2020","unstructured":"Baraka, E. A. et al. RETRACTED ARTICLE: Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment. Egypt. Rheumatol. Rehabil. 47 (1), 42 (2020).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"key":"48852_CR42","doi-asserted-by":"crossref","unstructured":"Almansouri, A. Y. et al. Comparison of remotely applied and face-to-face disease activity scores in Saudi Arabian patients with rheumatoid arthritis: A prospective cohort study. Cureus 16(1). (2024).","DOI":"10.7759\/cureus.52390"},{"key":"48852_CR43","doi-asserted-by":"crossref","unstructured":"Karaka\u015f, \u00d6., A\u011f\u0131r, M. & Erden, A. The relationship between disease activity, quality of life, and psychological status in patients with rheumatoid arthritis: A cross-sectional study (Journal of Turkish Society for Rheumatology, 2025).","DOI":"10.4274\/raed.galenos.2025.37450"},{"issue":"3","key":"48852_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5114\/reum.2022.117838","volume":"60","author":"N Nasir","year":"2022","unstructured":"Nasir, N., Majid, H., Khan, A. H., Awan, S. & Mehmood Riaz, M. Disease activity correlates and functionality in patients with rheumatoid arthritis\u2014real-world experience from a South Asian country. Reumatologia 60 (3), 183\u2013191 (2022).","journal-title":"Reumatologia"},{"issue":"3","key":"48852_CR45","doi-asserted-by":"publisher","first-page":"118","DOI":"10.5152\/eurjrheum.2020.20038","volume":"7","author":"R Coras","year":"2020","unstructured":"Coras, R. et al. Analysis of the correlation between disease activity score 28 and its ultrasonographic equivalent in rheumatoid arthritis patients. Eur. J. Rheumatol. 7 (3), 118\u2013123 (2020).","journal-title":"Eur. J. Rheumatol."},{"issue":"1","key":"48852_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s41927-024-00444-0","volume":"8","author":"M Masoumi","year":"2024","unstructured":"Masoumi, M. et al. Evaluation of hematological markers as prognostic tools in rheumatoid arthritis. BMC Rheumatol. 8 (1), 75 (2024).","journal-title":"BMC Rheumatol."},{"issue":"5","key":"48852_CR47","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.4103\/NRR.NRR-D-25-00026","volume":"21","author":"G Deng","year":"2026","unstructured":"Deng, G. et al. Interleukin-17 family in health and immune diseases: From origin to clinical implications. Neural Regener. Res. 21 (5), 1809\u20131833 (2026).","journal-title":"Neural Regeneration Res."},{"issue":"1","key":"48852_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejr.2015.01.001","volume":"38","author":"HM Al-Saadany","year":"2016","unstructured":"Al-Saadany, H. M., Hussein, M. S., Gaber, R. A. & Zaytoun, H. A. Th-17 cells and serum IL-17 in rheumatoid arthritis patients: Correlation with disease activity and severity. Egypt. Rheumatologist. 38 (1), 1\u20137 (2016).","journal-title":"Egypt. Rheumatologist"},{"issue":"3","key":"48852_CR49","doi-asserted-by":"publisher","first-page":"e0194883","DOI":"10.1371\/journal.pone.0194883","volume":"13","author":"T Dhaouadi","year":"2018","unstructured":"Dhaouadi, T. et al. IL-17A, IL-17RC polymorphisms and IL17 plasma levels in Tunisian patients with rheumatoid arthritis. PLoS ONE. 13 (3), e0194883 (2018).","journal-title":"PloS one"},{"issue":"3","key":"48852_CR50","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ejr.2020.02.009","volume":"42","author":"MA Farag","year":"2020","unstructured":"Farag, M. A., El Debaky, F. E., Abd El-Rahman, S. M., Abd el-khalek, S. M. & Fawzy, R. M. Serum and synovial fluid interleukin-17 concentrations in rheumatoid arthritis patients: Relation to disease activity, radiographic severity and power Doppler ultrasound. Egypt. Rheumatologist. 42 (3), 171\u2013175 (2020).","journal-title":"Egypt. Rheumatologist"},{"issue":"2","key":"48852_CR51","first-page":"123","volume":"43","author":"DA Diab","year":"2023","unstructured":"Diab, D. A., Ibrahim, N. H., Ismaeel, A. Y. & Rady, A. K. S. Assessment of serum interleukin-17 level and interleukin-17A gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. J. Clin. Immunol. 43 (2), 123\u2013130 (2023).","journal-title":"J. Clin. Immunol."},{"key":"48852_CR52","doi-asserted-by":"crossref","unstructured":"Abdel Fattah, M. A. et al. The relationship between interleukin 17A rs2275913 gene polymorphism and circulating IL17A levels and disease activity and severity in Egyptian rheumatoid arthritis patients. Expert Rev. Clin. Immunol. 2025 (just-accepted).","DOI":"10.1080\/1744666X.2025.2545907"},{"issue":"1","key":"48852_CR53","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10753-014-0020-1","volume":"38","author":"M Jain","year":"2015","unstructured":"Jain, M. et al. Increased plasma IL-17F levels in rheumatoid arthritis patients are responsive to methotrexate, anti-TNF, and T cell costimulatory modulation. Inflammation 38 (1), 180\u2013186 (2015).","journal-title":"Inflammation"},{"issue":"1","key":"48852_CR54","doi-asserted-by":"publisher","first-page":"23475","DOI":"10.1038\/s41598-024-72564-z","volume":"14","author":"NP Duarte-Delgado","year":"2024","unstructured":"Duarte-Delgado, N. P. et al. Cytokine profiles and their correlation with clinical and blood parameters in rheumatoid arthritis and systemic lupus erythematosus. Sci. Rep. 14 (1), 23475 (2024).","journal-title":"Sci. Rep."},{"key":"48852_CR55","doi-asserted-by":"crossref","unstructured":"Lapkina, N. et al. (eds) IL-17A, IL-17F, and IL-23 in patients with rheumatoid arthritis (Springer, 2025).","DOI":"10.1134\/S1607672925700139"},{"key":"48852_CR56","unstructured":"Illahi, M. I. et al. Serum tumor necrosis factor-alpha as a competent biomarker for evaluation of disease activity in early rheumatoid arthritis. Cureus 13(5). (2021)."},{"issue":"1","key":"48852_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s43166-024-00256-7","volume":"51","author":"AE Hassany","year":"2024","unstructured":"Hassany, A. E., Tharwat, S., Mansour, M. & Enein, A. F. TNF-\u03b1 in the serum and synovial fluid of patients with rheumatoid arthritis: correlation with sonographic parameters: A cross-sectional study. Egypt. Rheumatol. Rehabil. 51 (1), 22 (2024).","journal-title":"Egypt. Rheumatol. Rehabilitation"},{"issue":"4","key":"48852_CR58","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00296-022-05258-2","volume":"43","author":"TA Gheita","year":"2023","unstructured":"Gheita, T. A. et al. Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): Nationwide presentation and worldwide stance. Rheumatol. Int. 43 (4), 667\u2013676 (2023).","journal-title":"Rheumatol. Int."},{"key":"48852_CR59","first-page":"117954412412768","volume":"17","author":"SF Samaan","year":"2024","unstructured":"Samaan, S. F. et al. Role of Interleukin-17 in predicting activity of rheumatoid arthritis and systemic lupus erythematosus. Clin. Med. Insights Arthritis Musculoskelet. Disorders. 17, 11795441241276880 (2024).","journal-title":"Clin. Med. Insights: Arthritis Musculoskelet. Disorders"},{"issue":"1","key":"48852_CR60","doi-asserted-by":"publisher","first-page":"e0246111","DOI":"10.1371\/journal.pone.0246111","volume":"16","author":"K Dissanayake","year":"2021","unstructured":"Dissanayake, K., Jayasinghe, C., Wanigasekara, P. & Sominanda, A. Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-\u03b1, IL-1\u03b2, IL-10 and IL-17A. PLoS ONE. 16 (1), e0246111 (2021).","journal-title":"PloS one"},{"key":"48852_CR61","doi-asserted-by":"crossref","unstructured":"Ebaid, A. M. et al. Serum Interleukin-17 and its association with inflammation and bone remodeling in rheumatoid arthritis and hand osteoarthritis: Insights from musculoskeletal ultrasound. Diagnostics [Internet] 15(11). (2025).","DOI":"10.3390\/diagnostics15111335"},{"key":"48852_CR62","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.3389\/fimmu.2020.01894","volume":"11","author":"R Adams","year":"2020","unstructured":"Adams, R. et al. Bimekizumab, a novel humanized IgG1 antibody that neutralizes both IL-17A and IL-17F. Front. Immunol. 11, 1894 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"48852_CR63","doi-asserted-by":"publisher","first-page":"19223","DOI":"10.1038\/s41598-023-45653-8","volume":"13","author":"I Tout","year":"2023","unstructured":"Tout, I., Noack, M. & Miossec, P. Differential effects of interleukin-17A and 17F on cell interactions between immune cells and stromal cells from synovium or skin. Sci. Rep. 13 (1), 19223 (2023).","journal-title":"Sci. Rep."},{"issue":"3","key":"48852_CR64","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s40744-025-00754-w","volume":"12","author":"S Ramiro","year":"2025","unstructured":"Ramiro, S., Schett, G., Marzo-Ortega, H. & Schmidt, W. A. The impact of IL-17A inhibition in rheumatic and musculoskeletal diseases: Current insights and future prospects. Rheumatol. Therapy. 12 (3), 435\u2013451 (2025).","journal-title":"Rheumatol. Therapy"},{"issue":"10","key":"48852_CR65","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1007\/s11926-022-01084-4","volume":"24","author":"HKJ Tam","year":"2022","unstructured":"Tam, H. K. J., Robinson, P. C., Nash, P. & Inhibiting IL-17A and IL-17F in rheumatic disease: Therapeutics help to elucidate disease mechanisms. Curr. Rheumatol. Rep. 24 (10), 310\u2013320 (2022).","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"48852_CR66","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/rheumatology\/keac385","volume":"62","author":"VP Kouri","year":"2023","unstructured":"Kouri, V. P. et al. IL-17A and TNF synergistically drive expression of proinflammatory mediators in synovial fibroblasts via I\u03baB\u03b6-dependent induction of ELF3. Rheumatol. (Oxf.). 62 (2), 872\u2013885 (2023).","journal-title":"Rheumatol. (Oxford)"},{"key":"48852_CR67","doi-asserted-by":"publisher","first-page":"625034","DOI":"10.3389\/fimmu.2020.625034","volume":"11","author":"M Tang","year":"2020","unstructured":"Tang, M., Lu, L. & Yu, X. Interleukin-17A interweaves the skeletal and immune systems. Front. Immunol. 11, 625034 (2020).","journal-title":"Front. Immunol."},{"key":"48852_CR68","doi-asserted-by":"publisher","first-page":"828933","DOI":"10.3389\/fphar.2022.828933","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J., He, L., Li, W. & Lv, S. A role of IL-17 in rheumatoid arthritis patients complicated with atherosclerosis. Front. Pharmacol. 13, 828933 (2022).","journal-title":"Front. Pharmacol."},{"issue":"2","key":"48852_CR69","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen, H. et al. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheumatism Off. J. Am. Coll. Rheumatol. 62 (2), 383\u2013391 (2010).","journal-title":"Arthritis Rheumatism: Official J. Am. Coll. Rheumatol."},{"issue":"1","key":"48852_CR70","doi-asserted-by":"publisher","first-page":"15391","DOI":"10.1038\/s41598-021-94841-x","volume":"11","author":"G Vasilev","year":"2021","unstructured":"Vasilev, G. et al. The role of IL-18 in addition to Th17 cytokines in rheumatoid arthritis development and treatment in women. Sci. Rep. 11 (1), 15391 (2021).","journal-title":"Sci. Rep."},{"issue":"5","key":"48852_CR71","doi-asserted-by":"publisher","first-page":"393","DOI":"10.18786\/2072-0505-2019-47-058","volume":"47","author":"A Novikov","year":"2019","unstructured":"Novikov, A., Aleksandrova, \u0415. & Lukina, G. Serum cytokine profile in early and established rheumatoid arthritis. Almanac Clin. Med. 47 (5), 393\u2013399 (2019).","journal-title":"Almanac Clin. Med."},{"key":"48852_CR72","doi-asserted-by":"crossref","unstructured":"Zeb, S. et al. Relationship between serum interleukin-6 levels, systemic immune-inflammation index, and other biomarkers across different rheumatoid arthritis severity levels. Cureus 16(10). (2024).","DOI":"10.7759\/cureus.72334"},{"key":"48852_CR73","doi-asserted-by":"crossref","unstructured":"Sun, Q. & Dong, C. Regulators of CD8\u2009+\u2009T cell exhaustion. Nat. Rev. Immunol. 2025 1\u201323 .","DOI":"10.1038\/s41577-025-01221-x"},{"issue":"1","key":"48852_CR74","first-page":"73","volume":"53","author":"A Rosu","year":"2012","unstructured":"Rosu, A., Margaritescu, C., Stepan, A., Musetescu, A. & Ene, M. IL-17 patterns in synovium, serum and synovial fluid from treatment-naive, early rheumatoid arthritis patients. Rom J. Morphol. Embryol. 53 (1), 73\u201380 (2012).","journal-title":"Rom J. Morphol. Embryol."},{"issue":"5","key":"48852_CR75","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/15321819.2019.1649695","volume":"40","author":"CM Costa","year":"2019","unstructured":"Costa, C. M., Santos, M. A. T. D. & Pernambuco, A. P. Elevated levels of inflammatory markers in women with rheumatoid arthritis. J. Immunoass. Immunochem. 40 (5), 540\u2013554 (2019).","journal-title":"J. Immunoass. Immunochemistry"},{"key":"48852_CR76","unstructured":"Qu, C-H. et al. Diagnostic values of serum IL-10 and IL-17 in rheumatoid arthritis and their correlation with serum 14-3-3\u03b7 protein. Eur. Rev. Med. Pharmacol. Sci. ;23(5). (2019)."},{"issue":"1","key":"48852_CR77","doi-asserted-by":"publisher","first-page":"2276068","DOI":"10.1080\/08916934.2023.2276068","volume":"56","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. Potential significance of changes in serum levels of IL-17, TNF-\u03b1 and DKK-1 in the progression of the rheumatoid arthritis. Autoimmunity 56 (1), 2276068 (2023).","journal-title":"Autoimmunity"},{"issue":"7","key":"48852_CR78","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.ard.2025.04.018","volume":"84","author":"F Liu","year":"2025","unstructured":"Liu, F. et al. CD4\u2009+\u2009tissue-resident memory Th17 cells are a major source of IL-17A in Spondyloarthritis synovial tissue. Ann. Rheum. Dis. 84 (7), 1151\u20131163 (2025).","journal-title":"Ann. Rheum. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48852-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48852-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:04:56Z","timestamp":1780495496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48852-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,13]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48852"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48852-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,13]]},"assertion":[{"value":"29 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of Faculty of Medicine and Health Sciences, Sanaa University, Sana, Yemen, approved the experimental protocols of the current study. All methods were performed according to Helsinki Declaration. All study participants were provided with informed written consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The manuscript is in its present form, and the authors are all content with the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"17164"}}